For the control group, the incidence declined from 26 to 22.4%, which is not statistically significant.
Measles incidence declined until becomes a sporadic reporting and infrequent notification in the last decade.
For the treatment group, incidence declined substantially from 20.9 to 11.3%, which is statistically significant at the 1% level.
Meanwhile, the corresponding incidence declined less for the controls, from 24 to 18.8%, which is not statistically significant.
In the treatment group, the incidence declined from 8.6 to 5%, which is a decline of 3.6 percentage points, or 41.4% (significant at a 5% level).
Results: Controlling for maternal prenatal smoking and other confounders, SIDS incidence declined by >33% between the 2 survey years (adjusted odds ratio = 0.628 with 95% CI [0.598, 0.660]).
We find that for the treatment group, the reported incidence declined from 36.8% at the baseline to 29.6% post-intervention, or 18.7 percentage points (significant at a 5% level).
Giving this treatment, the diabetes incidence declined significantly.
Thus, while point estimates of HIV incidence declined by over one-third, neither the trend nor the association with CVL reached statistical significance.
Overall, among adults aged 15 49, incidence declined by 35% between the two inter-survey periods 2002 2005 and 2005 2008.
After these outbreaks, the incidence declined substantially.
